Dec'22 | Dec'23 | Dec'24 | Dec'25 | Dec'26 | Dec'27 | Dec'28 | Dec'29 | |
---|---|---|---|---|---|---|---|---|
Revenue growth | 48.9% | 25.6% | 22.4% | 18.6% | 23.7% | 17.0% | 7.4% | (6.1%) |
EPS growth | (48.3%) | 43.9% | 64.3% | 22.6% | 33.0% | 26.2% | 9.8% | (10.4%) |
Mar'15 | Jun'15 | Sep'15 | Dec'15 | Mar'16 | Jun'16 | Sep'16 | Dec'16 | Mar'17 | Jun'17 | Sep'17 | Dec'17 | Mar'18 | Jun'18 | Sep'18 | Dec'18 | Mar'19 | Jun'19 | Sep'19 | Dec'19 | Mar'20 | Jun'20 | Sep'20 | Dec'20 | Mar'21 | Jun'21 | Sep'21 | Dec'21 | Mar'22 | Jun'22 | Sep'22 | Dec'22 | Mar'23 | Jun'23 | Sep'23 | Dec'23 | Mar'24 | Jun'24 | Sep'24 | Dec'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue actual | $18.7M | $43.4M | $20.8M | $52.2M | $42.5M | $33.3M | $31.9M | $39.0M | $29.6M | $33.8M | $63.7M | $189.6M | $30.9M | $35.2M | $25.6M | $60.2M | $56.9M | $39.1M | $46.2M | $53.7M | $25.4M | $55.2M | $65.3M | $121.7M | $89.0M | $136.5M | $115.8M | $102.0M | $117.3M | $152.4M | $209.0M | $181.5M | $162.1M | $221.0M | $216.0M | $230.0M | $195.9M | $231.4M | $290.1M | $298.0M |
Revenue estimate | $20.3M | $20.3M | $20.3M | $20.3M | $53.1M | $53.1M | $53.1M | $53.1M | $28.5M | $28.5M | $28.5M | $28.5M | $35.8M | $35.8M | $35.8M | $35.8M | $67.8M | $42.8M | $55.0M | $56.9M | $43.0M | $66.7M | $59.9M | $120.0M | $84.9M | $104.1M | $105.8M | $101.5M | $128.3M | $138.6M | $191.2M | $192.1M | $179.3M | $200.0M | $216.1M | $231.0M | $199.7M | $204.9M | $252.2M | $285.7M |
Revenue surprise | 7.9% | 114.2% | 2.6% | 157.8% | 20.0% | 37.2% | 40.0% | 26.6% | 3.9% | 18.6% | 123.9% | 566.0% | 13.7% | 1.6% | 28.6% | 68.3% | 16.0% | 8.5% | 15.9% | 5.7% | 41.0% | 17.2% | 9.0% | 1.4% | 4.9% | 31.1% | 9.4% | 0.5% | 8.6% | 9.9% | 9.3% | 5.5% | 9.6% | 10.5% | 0.0% | 0.4% | 1.9% | 12.9% | 15.0% | 4.3% |
EPS actual | ($0.12) | $0.02 | ($0.19) | $0.03 | ($0.16) | ($0.21) | ($0.23) | ($0.22) | ($0.26) | ($0.23) | $0.02 | $0.87 | ($0.19) | ($0.16) | ($0.19) | ($0.02) | $0.01 | ($0.10) | ($0.17) | ($0.24) | ($0.04) | $0.19 | $0.27 | $0.54 | $0.20 | $0.64 | $1.53 | $0.48 | $0.44 | $0.16 | $0.45 | $0.43 | $0.29 | $0.57 | $0.62 | $0.66 | $0.61 | $0.73 | $1.08 | $1.08 |
EPS estimate | ($0.14) | ($0.14) | ($0.14) | ($0.14) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.24) | ($0.25) | ($0.25) | ($0.25) | ($0.25) | $0.01 | ($0.14) | ($0.12) | ($0.18) | ($0.02) | $0.25 | $0.19 | $0.53 | $0.32 | $0.43 | $0.42 | $0.38 | $0.46 | $0.47 | $0.36 | $0.30 | $0.38 | $0.63 | $0.71 | $0.83 | $0.69 | $0.76 | $0.99 | $1.16 |
EPS surprise | 14.3% | 114.3% | 35.7% | 121.4% | 33.3% | 12.5% | 4.2% | 8.3% | 8.3% | 4.2% | 108.3% | 462.5% | 24.0% | 36.0% | 24.0% | 93.9% | 27.9% | 29.2% | 40.0% | 31.8% | 114.3% | 22.8% | 38.6% | 2.1% | 37.1% | 47.2% | 261.3% | 24.8% | 4.6% | 66.0% | 24.4% | 43.9% | 24.2% | 9.5% | 12.2% | 20.0% | 11.1% | 3.8% | 9.0% | 6.8% |
Halozyme Therapeutics, Inc. (HALO) 1-year forward revenue growth is estimated at 18.6%.
Halozyme Therapeutics, Inc. (HALO) 1-year forward EPS growth is estimated at 22.6%.
Halozyme Therapeutics, Inc. (HALO) last reported EPS was $1.08, with a 6.8% miss.
Halozyme Therapeutics, Inc. (HALO) had 3 beats and 7 misses in its last 10 earnings reports.